Page 37 - ITPS-6-2
P. 37

INNOSC Theranostics and
            Pharmacological Sciences                                           Residual versus curative antimalarial tests




            Table 8. In vivo repository antimalarial activity of the aqueous and organic extracts of Morinda lucida in Plasmodium
            berghei‑infected mice
             Plant part  Extract    Dose   D  Parasite   D  Chemoprophylaxis   D  Parasite   D  Chemoprophylaxis   Mean survival
                                                                                  8
                                                                        8
                                                       6
                                            6
                                   (mg/kg)  density (%)     (%)        density (%)     (%)         time (days)
            Leaves      H O         100    7.18±1.09*      35.33       31.70±4.68*     39.96       11.25±1.89
                         2
                                    250     8.97±3.14      19.12       41.05±0.86      22.27        10.75±0.5
                                    400    6.54±0.48*      41.05       27.50±4.95*     47.92       12.50±1.73
            Positive control  Chloroquine  5  8.76±2.47    21.02       52.98±3.51     −0.32        12.25±2.06
            Negative control Distilled H O  0.2 mL  11.10±4.99  0.00   52.81±3.53      0.00         10.75±0.5
                               2
            Leaves      Organic     100     7.90±2.70      18.46       53.84±4.45      9.87         11.0±1.73
                                    250     7.57±1.57      21.9        52.73±2.74      11.72       11.40±3.21
                                    400     7.05±1.69      27.26       48.21±5.25      19.3        11.20±1.64
            Positive control  Chloroquine  5  7.34±4.62    24.25       67.48±3.28     −12.97       10.80±0.45
            Negative control Tween 80  0.2 mL  9.69±3.28   0.00        59.73±3.14      0.00        11.25±1.89
            Stem bark   H O         100    3.84±0.69*      39.36       38.15±2.88      20.19        10.0±0.82
                         2
                                    250    3.47±1.30*      45.26       37.56±1.15      21.42       10.33±0.58
                                    400    2.82±0.72*      55.52       32.48±2.97*     32.06       10.75±0.96
            Positive control  Chloroquine  5  4.40±1.05*   30.52       42.77±4.56      10.53       10.75±0.96
            Negative control Distilled H O  0.2 mL  6.33±1.30  0.00    47.80±2.42      0.00        10.50±1.00
                               2
            Stem bark   Organic     100    13.45±3.51      −18.12      60.07±6.30     −0.88        11.75±2.87
                                    250    12.09±6.71      −6.1        66.60±2.57     −11.86        10.25±0.5
                                    400    13.49±2.49      −18.44      82.85±1.74     −39.14       10.33±0.58
            Positive control  Chloroquine  5  9.85±1.89    13.56       58.34±4.71      2.02        12.50±2.38
            Negative control Tween 80  0.2 mL  11.39±0.75  0.00        59.54±3.56      0.00        11.25±1.89
            Notes: *Indicates significant difference from control, P≤0.05. Chemosuppression: ≥60%, high activity; 30 – 60%, moderate activity; <30%, weak
            activity; 0%, inactivity .
                          [13]
            insignificant increase (P > 0.05) (Table 11). The MST in   (curative test). This is observed in all the extracts tested in
            L.  inermis-treated group ranged from 10.50 ± 0.58 to 12.00   Figure 4.
            ± 1.83 days, while the positive and negative control groups
            had MST ranging from 10.75 ± 0.96 to 12.20 ± 1.64 days   4 Discussion
            and 10.50 ± 1.00 to 11.60 ± 0.55 days, respectively.  The  ethnobotanical  survey  conducted  in  Omu-Aran
                                                               showed that a variety of medicinal plants are traditionally
            3.2.2.5 C. odorata
                                                               used in the community for treating malaria. These plants
            On D , the extracts of  C. odorata extracts exhibited   are mostly consumed orally in the form of decoction.
                 7
            prophylactic activity ranging from weak (13.57%) to   Thirty-one species from 24 plant families were documented
            moderate (56.21%), with the DCM-MeOH (1:1) extract   during the survey conducted in this study, indicating
            groups showing better activity (Table 12). The MST ranged   the relevance of the medicinal flora in the day-to-day
            from 10.00 ± 0.82 to 12.60 ± 2.19 days for the mice treated   management of malaria in the area. Furthermore, most
            with C. odorata extracts. The positive and negative control   of the mentioned medicinal plants have been reported
            groups had MST ranging from 10.75 ± 0.96 to 12.20 ±   in other parts of Nigeria and Africa, and studies have
            1.64 days and 10.50 ± 1.00 to 11.60 ± 0.55 days, respectively   investigated their efficacy, yielding positive results. This
            (Table 12).                                        confirms the validity of the gathered information [25,26] .
                                                                 In the traditional medicine system, certain herbal
            3.2.3 Comparisons of curative and repository test   medicines are usually used for prevention before the
            results
                                                               onset of disease, while others are used after an infection
            Generally, better  in vivo antiplasmodial activity was   has already occurred. It is noteworthy that the same
            observed when extracts were administered before infection   plants often serve both preventive and curative purposes.
            (Repository test) than after the establishment of infection   Therefore, this study aimed to evaluate the antimalarial

            Volume 6 Issue 2 (2023)                         10                        https://doi.org/10.36922/itps.0300
   32   33   34   35   36   37   38   39   40   41   42